Vaxart Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +1,081.6% | -106.7% | – | – | |
| – | -41.9% | +81.4% | +1.7% | +0.5% | +0.5% | +0.5% | -4.3% | -3.3% | +14.5% | -52.7% | -34.2% | – | |
| – | -3.3% | +10.8% | -37.9% | -3.1% | -4.8% | +4.4% | -13.7% | -4.9% | -15.0% | -13.6% | -13.0% | – | |
| – | – | – | – | – | -151.1% | – | -228.4% | – | -555.8% | – | – | – | |
| – | -63.1% | +26.0% | +182.4% | -97.6% | +388.9% | +195.5% | -20.8% | +13.6% | -99.1% | +44,700.0% | -92.2% | – | |
| – | +203.9% | -133.3% | +92.4% | +76.3% | – | +27.2% | -45.3% | -180.5% | – | -134.0% | +301.8% | – | |
| – | +3,987.5% | -44.3% | -90.7% | -41.2% | +1,720.0% | – | – | – | – | – | – | – | |
| – | +725.0% | – | +110.2% | -100.0% | – | -220.6% | – | -103.2% | – | -107.9% | – | – | |
| – | – | -628.7% | – | -228.4% | – | +8.6% | -347.5% | – | – | -108.3% | – | – | |
| – | – | – | – | – | – | – | – | – | +1,137.4% | -108.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.